Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race

Core Insights - Mikael Dolsten, the former research and development chief of Pfizer, has withdrawn his candidacy for the board of Novo Nordisk due to personal reasons [1] Company Summary - Pfizer's former R&D chief, Mikael Dolsten, was a candidate for the board of Novo Nordisk but has decided to step back from this position [1] - Novo Nordisk is a Danish pharmaceutical company that is now seeking to fill the board position without Dolsten [1]